Targeting signal transduction pathways by chemopreventive agents

A M Bode1, Z Dong

  • 1Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, MN 55912, USA.

Mutation Research
|October 13, 2004
PubMed

Insights

Dietary factors like resveratrol and tea components show promise in cancer chemoprevention. These compounds may inhibit cancer growth by inducing apoptosis, blocking key signaling pathways, and reducing inflammation.

Area of Science:

  • Oncology
  • Nutritional Science
  • Molecular Biology

Background:

  • Cancer is a complex, multi-step disease with rising mortality rates, driving interest in chemoprevention.
  • Chemoprevention targets specific molecular and cellular steps in cancer development.
  • Nutritional and dietary factors are explored for their safety and potential as effective chemopreventive agents.

Purpose of the Study:

  • To review the mechanisms by which dietary factors act as chemopreventive agents.
  • To highlight the role of specific food compounds like resveratrol and tea components (EGCG, theaflavins, caffeine).
  • To focus on three key cellular/molecular mechanisms of anti-promotion.

Main Methods:

  • Literature review of recent research on chemoprevention.
  • Focus on cellular and molecular mechanisms of action for dietary compounds.
  • Analysis of how food factors inhibit cancer progression.

Main Results:

  • Dietary compounds can act as chemopreventive agents by preventing or reversing premalignant lesions.
  • Resveratrol and tea components (EGCG, theaflavins, caffeine) show documented efficacy.
  • These compounds target multiple signaling pathways involved in cancer development.

Conclusions:

  • Selected food factors demonstrate chemopreventive effects through specific mechanisms.
  • Mechanisms include induction of apoptosis in cancer cells.
  • Inhibition of neoplastic transformation via AP-1/NF-kappaB pathways and suppression of COX-2 overexpression are key actions.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...